[1]郭成浩, 边建朝, 王佾, 等.山东菏泽地区隔膜型布-加综合征外环境饮用水多元素测定[J].中国地方病学杂志, 2005, 24 (2) :207-209.
|
[2]Wang ZG, Zhang FJ, Meng QY, et al.Evolution of management of Budd-Chiari syndrome:a teams view from 2564 patients[J].ANZ J Surg, 2005, 75 (1-2) :55-63.
|
[3]Menon KVN, Shah V, Kamath PS.The Budd-Chiari syndrome[J].N Engl J Med, 2004, 350:578-585.
|
[4]Janssen HL, Garcia PJC, Elias E, et al.Budd-Chiari syndrome:a review by an expert panel[J].J Hepatol, 2003, 38 (3) :364-371.
|
[5]王佾, 张辉, 郭成浩, 等.下腔静脉隔膜阻塞性布-加综合征的病理学及病因学研究[J].介入放射学杂志, 2008, 17 (7) :500-503.
|
[6]汪旸, 陈晓东, 林大榕, 等.地理信息系统与流行病学分析[J].江苏省预防医学, 2003, 14 (4) :79-80.
|
[7]金鲁明, 郭成浩, 边建朝, 等.山东菏泽布-加综合征病人尿碘水平的测定[J].中国地方病防治杂志, 2005, 30 (4) :238-240.
|
[8]郭恩浦, 张辉, 张帆, 等.1997~2006年山东省布加综合征人群分布的研究[J].中国现代普通外科进展, 2008, 11 (4) :305-308.
|
[9]张海涛, 李加美, 郭成浩, 等.高碘对体外培养成纤维细胞增殖活性的影响[J].环境与健康杂志, 2007, 24 (6) :391-393.
|
[10]李麟荪.评布-加综合征意义与分型[J].介入放射学杂志, 2007, 16 (2) :75-78.
|
[11]Vaya A, Mira Y, Mateo J, et al.Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk[J].Thromb Haemost, 2003, 89 (3) :452-457.
|
[12]Lin GL, Xu PQ, Qi H, et al.Relations of Budd-Chiari syndrome to prothrombin gene mutation[J].Hepatobiliary Pancreat Dis Int, 2004, 3 (2) :214-218.
|
[1] | Xu GUO, Hao WU. Research advances in the diagnosis and treatment of hepatic vein occlusion-type Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2024, 40(1): 13-18. doi: 10.12449/JCH240102 |
[2] | Jing YANG, Suxin LI, Yuehui ZHANG, Luhao LI, Zhaochen LIU, Dongqi SHEN, Xiaowei DANG. Effect of metformin on liver fibrosis in a mouse model of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2022, 38(9): 2034-2039. doi: 10.3969/j.issn.1001-5256.2022.09.017 |
[3] | Cui ZHOU, Bo SHEN, Ying QU, Lungen LU. Current status of the clinical management of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2022, 38(7): 1474-1476. doi: 10.3969/j.issn.1001-5256.2022.07.005 |
[4] | Pang RunHua, Zhu YaQing. Hepatic dysplastic nodules with Budd-Chiari syndrome misdiagnosed as hepatocellular carcinoma: A case report[J]. Journal of Clinical Hepatology, 2020, 36(5): 1115-1116. doi: 10.3969/j.issn.1001-5256.2020.05.033 |
[5] | Wang LiBo, Sun YuLing. Establishment of Budd-Chiari syndrome models and related research advances[J]. Journal of Clinical Hepatology, 2020, 36(4): 908-911. doi: 10.3969/j.issn.1001-5256.2020.04.044 |
[6] | Wu KaiMin, Cao Shan, Zhang GuoYan, Chen GuoDong, Su Lin, Wang ZhiFeng, Liu YuLan. A case of paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome as the first manifestation[J]. Journal of Clinical Hepatology, 2018, 34(10): 2197-2199. doi: 10.3969/j.issn.1001-5256.2018.10.028 |
[7] | Yu Hong, Sun DianXing, Liang ZhiHui, Li HaiJun, Yang XinYing, Kang FuBiao. Diagnosis and interventional therapy for Budd-Chiari syndrome secondary to hepatic venous obstruction[J]. Journal of Clinical Hepatology, 2017, 33(7): 1340-1341. doi: 10.3969/j.issn.1001-5256.2017.07.028 |
[8] | Zhang WenWen, Qi XingShun, Guo XiaoZhong. Significance of factor Ⅱ G20210A mutation in Budd-Chiari syndrome and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 310-314. doi: 10.3969/j.issn.1001-5256.2015.02.043 |
[9] | Hu FengRong, Gao Fan, Yang Qing, Qi XingShun. Significance of factor V Leiden mutation in Budd- Chiari syndrome and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2014, 30(1): 86-89. doi: 10.3969/j.issn.1001-5256.2014.01.025 |
[10] | Xu Hao. Interventional therapy for intractable cases of Budd- Chiari syndrome[J]. Journal of Clinical Hepatology, 2013, 29(10): 748-751. doi: 10.3969/j.issn.1001-5256.2013.10.007 |
[11] | Peng Tao, Zhang GuoYan, Liu YuLan. Identification of Budd-Chiari syndrome, hepatic sinusoidal obstruction syndrome and hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1022-1026+1031. |
[12] | Bian Ce, Wang ZhongHao, Li Zhen, Li ChunMin. Severe Budd-Chiari syndrome with 18 years patency after mesojugular shunt (case report)[J]. Journal of Clinical Hepatology, 2011, 27(2): 199-200. |
[13] | Meng QingYi, Sun NianFeng, Wang RuiHua, Liu ZhaoXuan, Li Bo, Wang ZhongHao. Interventional treatment for Budd-Chiari syndrome:reports of 883 cases[J]. Journal of Clinical Hepatology, 2011, 27(2): 127-129. |
[14] | Wang Kun, Yu ZhenHai, Li GuangXin, Zhang ShuGuang, Qin ShiYong, Wang MingHai, Ruan ZhangLe. The application of interventional therapy for Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2011, 27(2): 123-126. |
[15] | Wang ZhongHao, Li ChunMin, Li Zhen, Bian Ce, Gu YongQuan, Yu HengXi, Chen Bing. Evolution and prospects of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2011, 27(2): 113-115. |
[16] | Li ChunMin, Bian Ce, Wang ZhongHao. Spontanously healing of Budd-Chiari syndrome:a case report[J]. Journal of Clinical Hepatology, 2011, 27(2): 198+20. |
[17] | Zheng YueHong, Shao Jiang, Song XiaoJun, Ren HuaLiang, Ye Wei, Liu Bao, Wu JiDong, Li YongJun, Liu ChangWei, Lu Xin, Sang XinTing. New surgical therapy for Budd-Chiari syndrome through a transabdominal approach[J]. Journal of Clinical Hepatology, 2011, 27(2): 201-202. |